INNOSEL

Serial Number 75593252
606

Registration Progress

Application Filed
Nov 23, 1998
Under Examination
May 16, 2000
Approved for Publication
Jan 21, 2000
Published for Opposition
Feb 22, 2000
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: INNOSEL
Previous Owner: Texas Biotechnology Corporation
Classes: 005

Trademark Image

INNOSEL

Basic Information

Serial Number
75593252
Filing Date
November 23, 1998
Published for Opposition
February 22, 2000
Abandonment Date
May 17, 2001
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 17, 2001
Classes
005

Rights Holder

Texas Biotechnology Corporation

03
Address
7000 Fannin, Suite 1920
Houston, TX 77030

Ownership History

Texas Biotechnology Corporation

Original Applicant
03
Houston, TX

Texas Biotechnology Corporation

Owner at Publication
03
Houston, TX

Legal Representation

Attorney
Joseph M. Vanek

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

11 events
Date Code Type Description Documents
Aug 14, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 26, 2000 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 27, 2000 EXT1 S SOU EXTENSION 1 FILED Loading...
May 16, 2000 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 22, 2000 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 21, 2000 NPUB O NOTICE OF PUBLICATION Loading...
Nov 19, 1999 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 7, 1999 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 7, 1999 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 13, 1999 CNSL F LETTER OF SUSPENSION MAILED Loading...
May 4, 1999 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Pharmaceutical preparation for the treatment of heart failure, essential hypertension, prostate cancer pulmonary hypertension subarachnoid hemorrhage asthma Psoriasis and organ reperfusion injury
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005